Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses

This publication has 28 references indexed in Scilit:

• Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
  PLoS Medicine, 2006
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
  The Lancet, 2006
• Immunization with Reverse‐Genetics–Produced H5N1 Influenza Vaccine Protects Ferrets against Homologous and Heterologous Challenge
  The Journal of Infectious Diseases, 2006
• The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate
  Vaccine, 2006
• Influenza and the challenge for immunology
  Nature Immunology, 2006
• Evolution of H5N1 Avian Influenza Viruses in Asia
  Emerging Infectious Diseases, 2005
• Influenza: lessons from past pandemics, warnings from current incidents
  Nature Reviews Microbiology, 2005
• Efficacy of H5 Influenza Vaccines Produced by Reverse Genetics in a Lethal Mouse Model
  The Journal of Infectious Diseases, 2005
• Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
  Vaccine, 2005
• Influenza: Emergence and Control
  Journal of Virology, 2004